This is great news and an amazingly strong outcome! Proxalutamide is an antiandrogen, which reduces some of the effects of androgens including testosterone, so

This is great news and an amazingly strong outcome! Proxalutamide is an antiandrogen, which reduces some of the effects of androgens including testosterone, so I wonder if this has a stronger effect in males than in females. Although the paper mentions the sex distribution of the patients, it doesn't seem to mention the details necessary to conclude this, but unless I'm mistaken over something trivial I'm unsure as to why. Anyone have any thoughts?